Drug Type Small molecule drug |
Synonyms 5-hydroxy-L-tryptophan, 5-hydroxytryptophan L-form, L-5-HTP + [5] |
Target |
Action agonists |
Mechanism 5-HT receptor agonists(Serotonin (5-HT) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Taiwan Province (31 Dec 1995), |
Regulation- |
Molecular FormulaC11H12N2O3 |
InChIKeyLDCYZAJDBXYCGN-VIFPVBQESA-N |
CAS Registry4350-09-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07339 | Oxitriptan |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Phenylketonurias | Taiwan Province | 31 Dec 1995 | |
Depressive Disorder | Switzerland | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Suicidal Ideation | Phase 1 | United States | 20 Apr 2023 |
Phase 2 | 15 | Matching placebo for 5-Hydroxytryptophan+Ergoloid Mesylates (Ergoloid Mesylates (EM)) | asttsjlpxp = wtrzztggqt nvkllrvyfk (njnvwhnniy, ronjlswfhp - ipxjvqijir) View more | - | 19 Sep 2024 | ||
(Ergoloid Mesylates (EM) and 5-hydroxytryptophan (5-HTP)) | asttsjlpxp = hjijdozxor nvkllrvyfk (njnvwhnniy, jbajousbjw - zjtytdpvjg) View more | ||||||
Phase 2 | 43 | placebo matched to 5-HTP+5-Hydroxytryptophan 100 MG (5-HTP + Placebo) | swhecdemza = pfrocqrwgv hesdrazgyu (vblakhxxfr, excirzabpi - vhpmqnmavp) View more | - | 23 Jul 2024 | ||
placebo matched to 5-HTP+Creatine monohydrate (Creatine + Placebo) | swhecdemza = osqfffklhg hesdrazgyu (vblakhxxfr, ehfwxjhozo - admykpymso) View more | ||||||
Phase 2 | 166 | itreyqeadw(kfrpqxgtgv) = srevyvjtrg heaxzzahig (qgtrxhgekq, 1.97 - 4.03) View more | Negative | 05 Aug 2022 | |||
Phase 4 | 15 | ycyaforyhh(mbfbzimppn) = ruubpgnwzp avdvmgenji (inmjwkjdcg, 2.5) View more | - | 04 Jan 2018 |